Sonablate

System Information

Operations

Results

Users

Clinical Publications

THS International

Home

Distribution Information

Contact Information

SONABLATE^® 500
 

Who is Using It?

Over 240 leading urologists around the world are using the advanced Sonablate^® 500 HIFU system for localized prostate cancer therapy in over 100 medical centers around the world.  In addition, there have been over 10,000 men treated with the Sonablate^® 500 HIFU system for localized prostate cancer. 

Numerous publications on the clinical efficacy and low side effects and complications have been published detailing worldwide clinical data on the HIFU therapy for prostate cancer has been established.

 Key Market Teaching Centers

 

Japan	Australia
Prof. Toyoaki Uchida Tokai University Hachioji Hospital 1838 Ishikawa-machi Hachioji, Tokyo 192-0032 Japan Tel: (81) 42-639-1111 Email: toyoaki2569uchida@vesta.ocn.ne.jp	Dr. Peter Royce Urologist Cabrini Medical Centre Suite 51 Isabella St. Malvern, VIC 31 44 Australia Ph: +61-3-9500-9333 Email: peter.royce@med.monash.edu.au http://www.melbournehifu.com.au
Israel	Vietnam
Abraham Ami Sidi, M.D. Chairman, Department of Urologic Surgery The Edith Wolfson Medical Center 62, Halochamim St. P.O.B. 5 Holon, 58100, ISRAEL Email: sidi@wolfson.health.gov.il Website: www.hifu-israel.co.il	David NGUYEN HOANG DUC  M.D., MS Consultant Urologist Section of Endourology and MIS Department of Surgery University Medical Centre Ho Chi Minh City – Vietnam Email: hoangduc73@yahoo.com

©2005-2011 THS International, Inc.